中文摘要：

[目的]观察参仙升脉对缓慢性心律失常患者生活质量影响。[方法]使用随机平行对照方法，将51例住院及门诊患者按随机数字表分为两组。对照组29例根据病情安装人工心脏起搏器。治疗组22例参仙升脉口服液．20mL／次．2次／d。连续治疗1个月为1疗程。观测临床症状、SF-36量表评分、不良反应。治疗1疗程．判定疗效。[结果]治疗组显效6例．有效12例．无效4例。总有效率81．82％。对照组显效20例．有效8例．无效1例．总有效率96．55％。两组间均无明显差糸P〉0．05）。SF-36量表评分两组均有明显升高（P〈0．05）．生理职能、躯体疼痛、情感职能、总体健康等治疗组升高低于对照组（P〈0．05）。[结论]参仙升脉治疗缓慢性心律失常，疗效满意。无副作用。值得推广。

英文摘要：

[ Objective ] To observe the use of SF-36 scale evaluation Shenxian shengmai oral impact on quality of life in patients with bradyarrhythmias. [ Method ] random parallel control Method, 51 cases of hospitalized and outpatients were randomly divided into two groups. A control group of 29 patients according to the disease to install artificial cardiac pacemaker. Treated 22 cases of oral argument cents liter veins, 20mL / times, bid. Continuous treatment one month course of treatment. Observation of clinical symptoms, the score of SF-36, adverse reactions. A course of treatment with one month to determine efficacy. [ Results ] Treatment group six cases effective obviously, effective in 12 cases, 4 cases with no effect, the total efficiency of 81.82%. The control group, 20 cases markedly effective in 8 cases, one case with no effect, the total efficiency of 96.55%. There were no significant differences between the two groups （ P〉0.05 ） . SF-36 scores were significantly higher in both groups （ P〈0.05 ）, physical function, bodily pain, role emotional, general health and other treatment group than the control group increased （ P〈0.05 ） . [ Conclusion ] The Results of treating bradyarrhythmias with Shenxian shengmai oral were satisfactory, and no side effects, it is worth promoting.